E. Becerra-Martínez et al. / Tetrahedron: Asymmetry xxx (2017) xxx–xxx
5
0
0
0
0
0
0
4
.3. (1S,2R,5R,7S,9R,1 R)-5-(2 -Hydroxybut-2 -yl)-3,3,10,10-tetra-
25.6 (C-12), 25.2 (C-6 ), 24.5 (C-5 ), 23.3 (C-4 ), 21.5 (C-14), 19.4
2,7
ꢀ1
methyl-4,6-dioxatricyclo[7.1.1.0 ]undecane 11a
(C-15). IR (CHCl3): 3587, 2952, 1464, 1369, 1095, 964 cm . MS
+
m/z (rel. int.): 309 (M ꢀ1, 3), 209 (41), 163 (100), 135 (41), 121
4
.3.1. Obtained using method 2
(48), 110 (76), 108 (39), 98 (13), 85 (10), 71 (13).
Compound 4 (80 mg, 0.31 mmol) in anhydrous ethyl ether
0
0
0
0
(
(
10 mL) was treated with 0.07 mL (1 mmol) of EtBr and 24 mg
1 mmol) of magnesium. After work-up, 67 mg (75%) of
4.6. (1S,2R,5R,7S,9R,1 R)-5-(1 -Hydroxy-1 -phenyleth-1 -yl)-3,3,
2
,7
a
10,10-tetramethyl-4,6-dioxatricyclo[7.1.1.0 ]undecane 11d
diastereoisomeric mixture of carbinols 11a:12a (84:16) were
1
obtained as a colorless syrup. (R
NMR (CDCl ): d 4.69 (1H, s, H-5), 4.49 (1H, dd, J = 8.7 Hz, H-7),
.64 (1H, m, H-11eq), 2.34 (1H, m, H-8eq), 2.24 (1H, bs, OH), 2.09
2H, m, H-2, H-9), 1.94 (1H, t, J = 6 Hz, H-1), 1.70 (1H, m, H-8ax),
f
0.48, hexanes-AcOEt 9:1).
H
4.6.1. Method 3
3
A well-stirred cooled (ꢀ78 °C) solution of 84 mg (0.33 mmol) of
acetyldioxane 4 in 10 mL of anhydrous THF was treated with
0.55 mL (0.99 mmol) of 1.8 M PhLi in cyclohexane and stirred
2
(
0
0
1
.56 (2H, m, H-3 ), 1.26 (3H, s, Me-1 ), 1.24 (3H, s, Me-15), 1.20
2
under an N atmosphere for 3 h. The mixture was quenched with
(
3H, s, Me-13), 1.13 (3H, s, Me-14), 1.08 (3H, s, Me-12), 1.05 (1H,
1.5 mL of a saturated solution of ammonium chloride and allowed
to warm up to room temperature. The THF was evaporated and the
residue was extracted with 50 mL of ethyl ether. The organic layer
was washed with 5% aq HCl (3 ꢁ 10 mL), dried over anhydrous
0
13
d, J = 9.6 Hz, H-11ax), 0.92 (3H, t, J = 7.6 Hz, Me-4 ). C NMR (CDCl
d 100.1 (C-5), 76.7 (C-3), 73.4 (C-2 ), 70.8 (C-7), 58.1 (C-2), 43.5 (C-1),
4
1
3
):
0
0
3.3 (C-9), 41.5 (C-11), 39.5 (C-10), 33.1 (C-8), 30.2 (C-1 ), 29.5 (C-
0
0
3), 29.3 (C-3 ), 25.7 (C-12), 21.5 (C-14), 19.4 (C-15), 7.5 (C-4 ). IR
2 4
Na SO , filtered, and evaporated to dryness. The residue was puri-
ꢀ
1
(
CHCl
3
): 3586, 2975, 1457, 1379, 1155, 1095 cm . MS m/z (rel.
fied by column chromatography using silica gel and a mixture of
hexanes-AcOEt as eluent to give 101 mg (92%) of carbinols
11d:12d (50:50) as a colorless syrup.
+
int.): 281 (M ꢀ1, 0.3), 163 (15), 121 (22), 107 (34), 91 (22), 79
(
100), 67 (66), 55 (29), 43 (53), 41 (48), 39 (25).
0
0
0
4
.4. (1S,2R,5R,7S,9R,1 R)-5-(2 -Hydroxybut-3-en-2 -yl)-3,3,10,10-
4.6.2. Obtained using method 1
2,7
tetramethyl-4,6-dioxatricyclo[7.1.1.0 ]undecane 11b
Compound 4 (72 mg, 0.28 mmol) in anhydrous THF (10 mL) was
treated with 1 M PhMgBr (0.86 mL, 86 mmol) in ether. After work-
up, 85 mg (90%) of a diastereoisomeric mixture of carbinols
4
.4.1. Obtained using method 1
Obtained using method 1: Compound 4 (90 mg, 0.35 mmol) in
11d:12d (77:23) was obtained as a colorless syrup. (R
f
0.34, hex-
1
anhydrous THF (10 mL) was treated with 1.0 M i-PrMgBr
0.90 mL, 0.90 mmol) in ether. After work-up, 85 mg (80%) of a
diastereoisomeric mixture of carbinols 11b:12b (62:38) were
anes-AcOEt 98:2). H NMR (CDCl ): d 7.54 (2H, d, J = 8.5 Hz, H-
3
(
ortho), 7.31 (2H, dd, J = 7.2, 8.5 Hz, H-meta), 7.24 (1H, d,
J = 7.2 Hz, H-para), 4.92 (1H, s, H-5), 4.47 (1H, bt, J = 8.7 Hz, H-7),
3.07 (1H, bs, OH), 2.62 (1H, m, H-11eq), 2.30 (1H, m, H-8eq), 2.09
(2H, m, H-2, H-9), 1.92 (1H, t, J = 6.9 Hz, H-1), 1.78 (1H, m, H-
1
obtained as a colorless syrup. (R
NMR (CDCl ): d 4.67 (1H, s, H-5), 4.48 (1H, dd, J = 8.7 Hz, H-7),
.63 (1H, m, H-11eq), 2.35 (1H, m, H-8eq), 2.22 (1H, s, –OH),
f
0.45, hexanes-AcOEt 98:2). H
3
0
2
2
8ax), 1.52 (3H, s, Me-2 ), 1.24 (3H, s, Me-15), 1.19 (6H, s, Me-
0
13
.10 (2H, m, H-2, H-9), 1.97 (1H, c, J = 6.9 Hz, H-3 ), 1.95 (1H, t,
13,14), 1.05 (1H, d, J = 9.5 Hz, H-11ax), 1.04 (3H, s, Me-12).
C
0
J = 6.0 Hz, H-1), 1.71 (1H, m, H-8ax), 1.25 (3H, s, Me-1 ), 1.22
NMR (CDCl ): d 145.2 (C-ipso), 127.9 (C-meta), 126.8 (C-para),
3
0
(
(
3H, s, Me-15), 1.18 (3H, s, Me-13), 1,11 (3H, s, Me-14), 1.08
3H, s, Me-12), 1.05 (1H, d, J = 9.6 Hz, H-11ax), 0.95 (3H, d,
126.2 (C-ortho), 100.5 (C-5), 77.5 (C-3), 74.9 (C-1 ), 71.1 (C-7),
58.1 (C-2), 43.6 (C-1), 43.5 (C-9), 41.7 (C-11), 39.6 (C-10), 33.2
(C-8), 30.3 (C-15), 29.6 (C-13), 25.9 (C-12), 24.6 (C-2 ), 19.6 (C-
0
0
13
0
J = 6.6 Hz, Me-5 ), 0.92 (3H, d, J = 6.9 Hz, Me-4 ). C NMR (CDCl
3
):
0
ꢀ1
d 100.2 (C-5), 76.5 (C-3), 73.3 (C-2 ), 70.9 (C-7), 58.3 (C-2), 43.2
C-1), 43.4 (C-9), 41.5 (C-11), 39.4 (C-10), 33.4 (C-3 ), 33.6 (C-8),
0.2 (C-1 ), 29.5 (C-13), 25.5 (C-12), 21.4 (C-14), 19.4 (C-15),
3
7.7 (C-4 ), 17.1 (C-5 ). IR (CHCl ): 2953, 1457, 1356, 1150,
14). IR (CHCl
3
): 3566, 2976, 1493, 1447, 1379, 1153, 1093 cm
.
0
+
(
MS m/z (rel. int.): 330 (M , 0.3), 163 (146), 135 (16), 121 (51),
0
3
1
1
2
107 (72), 91 (68), 79 (100), 67 (48).
0
0
ꢀ
1
+
0
0
0
0
085 cm . MS m/z (rel. int.): 297 (M +1, 2), 279 (1), 253 (3),
4.7.
(1S,2R,5R,7S,9R,1 R)-5-(2 -Hydroxy-3 -buten-2 -yl)-3,3,10,
2
,7
09 (37), 181 (8), 163 (98), 135 (41), 121 (52), 109 (100), 95
10-tetramethyl-4,6-dioxatricyclo[7.1.1.0 ]undecane 11e
(
22), 43 (25).
4
.7.1. Obtained using method 1
Compound 4 (60 mg, 0.23 mmol) in anhydrous THF (10 mL) was
0
0
0
0
4
1
.5. (1S,2R,5R,7S,9R,1 R)-5-(4 -Methyl-2 -hydroxypent-2 -yl)-3,3,
0,10-tetramethyl-4,6-dioxatricyclo[7.1.1.02,7]undecane 11b
treated with 2 M CH
After work-up, 64 mg (96%) of a diastereoisomeric mixture of car-
binols 11e:12e (65:35) were obtained as a colorless syrup (R 0.4,
): d 6.03 (1H, dd, J = 10.8,
2
@CHMgBr (0.35 mL, 0.71 mmol) in ether.
4
.5.1. Obtained using method 1
Compound 4 (100 mg, 0.39 mmol) in anhydrous THF (10 mL)
was treated with 1.0 M i-BuMgBr (0.96 mL, 0.96 mmol) in ether.
After work-up, 110 mg (89%) of a diastereoisomeric mixture of car-
f
1
hexanes-AcOEt 9:1). H NMR (CDCl
3
0
0
17.4 Hz, H-3 ), 5.36 (1H, dd, J = 1.7, 17.4 Hz, H-4 a), 5.12 (1H, dd,
J = 1.7, 10.8 Hz, H-4 b), 4.70 (1H, s, H-5), 4.49 (1H, dd, J = 8.7 Hz,
0
binols 11c:12c (60:40) were obtained as a colorless syrup. (R
hexanes-AcOEt 98:2). 1H NMR (CDCl
): d 4.69 (1H, s, H-5), 4.49
1H, dd, J = 8.7 Hz, H-7), 2.64 (1H, m, H-11eq), 2.34 (1H, m, H-
f
0.45,
H-7), 2.63 (1H, m, H-11eq), 2.53 (1H, m, H-2), 2.33 (1H, m, H-
3
8eq), 2.08 (1H, m, H-9), 1.93 (1H, t, J = 6.0 Hz, H-1), 1.77 (1H, m,
0
(
H-8ax), 1.26 (3H, s, Me-1 ), 1.25 (3H, s, Me-15), 1.24 (3H, s, Me-
8
eq), 2.24 (1H, bs, –OH), 2.09 (2H, m, H-2, H-9), 1.94 (1H, t,
13), 1.21 (3H, s, Me-14), 1.07 (3H, s, Me-12), 1.06 (1H, d,
0
13
0
0
J = 6.0 Hz, H-1), 1.82 (m, 1H, H-4 ), 1.70 (1H, m, H-8ax), 1.45 (m,
J = 8.4 Hz, H-11ax). C NMR d 141.6 (C-3 ), 113.3 (C-4 ), 100.4 (C-
0
0
0
2
H, H-3 ), 1.26 (3H, s, Me-1 ), 1.24 (3H, s, Me-15), 1.20 (3H, s,
5), 77.2 (C-3), 74.0 (C-2 ), 71.0 (C-7), 58.1 (C-2), 43.6 (C-1), 43.4
Me-13), 1.13 (3H, s, Me-14), 1.08 (3H, s, Me-12), 1.05 (1H, d,
(C-9), 41.5 (C-11), 39.6 (C-10), 33.1 (C-8), 30.3 (C-15), 29.6 (C-
0
0
J = 9.6 Hz, H-11ax), 0.98 (d, 3H, J = 6.6 Hz, CH3-5 ), 0.95 (d, 3H,
13), 25.9 (C-12), 22.7 (C-1 ), 19.6 (C-14). IR (CHCl
3
): 3580, 2976,
0
13
ꢀ1
J = 6.7 Hz, CH3-6 ). C NMR (CDCl
7
9
3
): d 100.3 (C-5), 76.4 (C-3),
1646, 1456, 1379, 1155, 1093 cm . MS m/z (rel. int.): 279
0
0
+
3.1 (C-2 ), 70.7 (C-7), 58.4 (C-2), 44.7 (C-3 ), 43.5 (C-1), 43.1 (C-
), 41.6 (C-11), 39.4 (C-10), 33.0 (C-8), 30.1 (C-1 ), 29.4 (C-13),
(M ꢀ1, 0.2), 181 (15), 163 (100), 121 (13), 107 (28), 79 (54), 67
0
(40), 55 (18), 43 (73), 41 (45), 39 (27).